SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1721)12/7/2006 1:35:04 PM
From: Steve Lokness  Read Replies (1) | Respond to of 3722
 
Bernard;

Do you give P&F charting any consideration? And, what are your thoughts as to the effectiveness of TA with biotechs?

Assuming you look at P&F charts, is not now a good time to look seriously at SGEN?

stockcharts.com[PA][D][F1!3!!!2!20]&pref=G

Respectfully;
Steve



To: Jibacoa who wrote (1721)6/4/2007 2:37:40 PM
From: Jibacoa  Respond to of 3722
 
Introgen Announces Positive Phase 2 Clinical Trial Results with INGN 225 Immunotherapy in Patients with Small Cell Lung Cancer

Message 23596819

The stock needs to close above the resistance at the $5 level, before trying to test the more important one from the Apr18 H at $6.35 <g>

bigcharts.marketwatch.com

Bernard


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News